D&P Biotech Overview
- Year Founded
-
2006
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
6
D&P Biotech General Information
Description
Developer of molecular diagnostics DNA (Deoxyribonucleic acid) biomarkers designed to provide customized treatments. The company's molecular diagnostics DNA biomarkers are effective and help to detect and manage lung cancer, enabling patients to begin treatment more quickly and resulting in a higher likelihood of successful treatment.
Contact Information
Website
www.dnpbiotech.comCorporate Office
- Room 902, 9th Floor, 92 Beopwon-ro
- Songpa-gu, Munjeong-dong, Partners 1
- Seoul, 05836
- South Korea
Corporate Office
- Room 902, 9th Floor, 92 Beopwon-ro
- Songpa-gu, Munjeong-dong, Partners 1
- Seoul, 05836
- South Korea
D&P Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
D&P Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
D&P Biotech FAQs
-
When was D&P Biotech founded?
D&P Biotech was founded in 2006.
-
Where is D&P Biotech headquartered?
D&P Biotech is headquartered in Seoul, South Korea.
-
What industry is D&P Biotech in?
D&P Biotech’s primary industry is Biotechnology.
-
Is D&P Biotech a private or public company?
D&P Biotech is a Private company.
-
What is D&P Biotech’s current revenue?
The current revenue for D&P Biotech is .
-
Who are D&P Biotech’s investors?
Golden Oak Investment, S2L Partners, and KT Investment have invested in D&P Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process